LASSEN THERAPEUTICS
Lassen Therapeutics develops antibodies as potential treatments for fibrosis, rare diseases, and oncology. The companyโs lead candidate is LASN01, a best-in-class monoclonal antibody targeting IL-11 receptor alpha (IL-11R). IL-11, a member of the IL-6 family of cytokines, is a central mediator of fibrosis and blocking its activity has the potential to be more effective than targeting other factors such as TGF-ฮฒ and CTGF. IL-11 is also a pivotal effector of tumor microenvironment organization and tumor growth, playing a key role as a mediator between cancer and stromal cells.
LASSEN THERAPEUTICS
Industry:
Biotechnology Life Science
Founded:
2018-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.lassentherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
(858) 251-7528
Email Addresses:
[email protected]
Total Funding:
31 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API WordPress Wordpress Plugins Nginx Sitelinks Search Box Microsoft Exchange Online
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Viking Therapeutics
Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Advisors List
Current Employees Featured
Founder
Investors List
Alta Partners
Alta Partners investment in Series A - Lassen Therapeutics
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series A - Lassen Therapeutics
Longwood Fund
Longwood Fund investment in Series A - Lassen Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-18 | Lassen Therapeutics Appoints Puneet S. Arora M.D. as Chief Medical Officer |
Official Site Inspections
http://www.lassentherapeutics.com Semrush global rank: 8.08 M Semrush visits lastest month: 376
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
